Project cooperationUpdated on 10 April 2026
Early stage cancer diagnostics based on analysis of glycans in blood serum
About
Primary focus: prostate cancer, breast cancer, pancreatic cancer, lung cancer.
Further targets: stomach, colorectal, ovarian, testitular, liver,bladder, thyroid cancer.
Topic
- Biotech, Pharma and Cosmetics
Type
- Research
Similar opportunities
Expertise
Oncology R&D leadership, translational strategy and platform building
- Biotech, Pharma and Cosmetics
Christoph Lampert
Vice President & Site Head | Biophamaceutical Executive at Xilis
Den Haag, Netherlands
Partnership
Enhancing antitumoral drugs with our "smart antitumoral nanovectors"
Ana Bouchet
CEO at Lifesome Therapeutics
MADRID, Spain